FDA staff: Novo Nordisk drug liraglutide effective for obesity
September 09, 2014 at 09:32 AM EDT
WASHINGTON, Sept 9 (Reuters) - Novo Nordisk's drug liraglutide appears effective in treating obesity, according to a preliminary assessment by reviewers at the U.S. Food and Drug Administration released on Tuesday.
